Hot Investor Mandate 3: New Venture Fund Invests Early in Therapeutics and Research Tools

3 Aug

A global innovation incubator and investment group based in San Francisco, CA focuses on biomedical R&D technologies and therapeutics. In addition to an incubator for early-stage life science companies, the group has assembled a senior team of investors and executives and had their first close of a new, early-stage venture fund at $80M and is expecting a second close at $200M in Q2 of 2018. The firm will invest in seed and series A rounds in companies in the U.S. and China, and targets initial investments of up to $5M. The firm usually participates as a co-investor in a syndicate, but going forward looks to lead more priced financing rounds. The group is flexible with deal structures and may employ convertibles, straight equity, etc. depending on the needs of the company.

The firm is primarily focused on therapeutics and research tools (ex. CRISPR) and is open to most modalities, but has the most interest and expertise in antibodies and immune modulator drugs. As for therapeutic areas, the group is most interested in oncology and cognitive disorders, but will also consider therapeutics in other indications and looks to broaden their portfolio going forward.

The firm has no strict requirements for companies or management teams and is comfortable working with first-time or novice entrepreneurs as the firm’s leadership team has deep experience in the life sciences space and looks to provide guidance and strategic direction to portfolio companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: